Form 8-K - Current report:
SEC Accession No. 0001641172-25-015249
Filing Date
2025-06-16
Accepted
2025-06-16 16:15:38
Documents
12
Period of Report
2025-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 79119
  Complete submission text file 0001641172-25-015249.txt   252262

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pulm-20250616.xsd EX-101.SCH 3017
3 XBRL LABEL FILE pulm-20250616_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE pulm-20250616_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 251050264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)